Drug Profile
Research programme: amyloid precursor protein secretase inhibitors - FORUM
Alternative Names: EVP 15962; EVP-14936Latest Information Update: 25 Nov 2016
Price :
$50
*
At a glance
- Originator EnVivo Pharmaceuticals
- Developer FORUM Pharmaceuticals
- Class Small molecules
- Mechanism of Action Amyloid precursor protein secretase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 01 Jun 2016 Discontinued - Preclinical for Alzheimer's disease in USA (PO)
- 02 Apr 2014 EnVivo Pharmaceuticals is now called FORUM Pharmaceuticals
- 14 Jul 2009 Preclinical trials in Alzheimer's disease in USA (PO)